Global Covid-19 Vaccine Market Growth (Status and Outlook) 2024-2031

Report ID: 1168664 | Published Date: Jan 2025 | No. of Page: 124 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Covid-19 Vaccine Market Size 2017-2028
        2.1.2 Covid-19 Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Covid-19 Vaccine Segment by Type
        2.2.1 DNA
        2.2.2 Live Attenuated Virus
        2.2.3 NonReplicating Viral Vecto
        2.2.4 Protein Subunit
        2.2.5 RNA
    2.3 Covid-19 Vaccine Market Size by Type
        2.3.1 Covid-19 Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Covid-19 Vaccine Market Size Market Share by Type (2017-2022)
    2.4 Covid-19 Vaccine Segment by Application
        2.4.1 Treatment
        2.4.2 Prevention
    2.5 Covid-19 Vaccine Market Size by Application
        2.5.1 Covid-19 Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Covid-19 Vaccine Market Size Market Share by Application (2017-2022)
3 Covid-19 Vaccine Market Size by Player
    3.1 Covid-19 Vaccine Market Size Market Share by Players
        3.1.1 Global Covid-19 Vaccine Revenue by Players (2020-2022)
        3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2020-2022)
    3.2 Global Covid-19 Vaccine Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Covid-19 Vaccine by Regions
    4.1 Covid-19 Vaccine Market Size by Regions (2017-2022)
    4.2 Americas Covid-19 Vaccine Market Size Growth (2017-2022)
    4.3 APAC Covid-19 Vaccine Market Size Growth (2017-2022)
    4.4 Europe Covid-19 Vaccine Market Size Growth (2017-2022)
    4.5 Middle East & Africa Covid-19 Vaccine Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Covid-19 Vaccine Market Size by Country (2017-2022)
    5.2 Americas Covid-19 Vaccine Market Size by Type (2017-2022)
    5.3 Americas Covid-19 Vaccine Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Covid-19 Vaccine Market Size by Region (2017-2022)
    6.2 APAC Covid-19 Vaccine Market Size by Type (2017-2022)
    6.3 APAC Covid-19 Vaccine Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Covid-19 Vaccine by Country (2017-2022)
    7.2 Europe Covid-19 Vaccine Market Size by Type (2017-2022)
    7.3 Europe Covid-19 Vaccine Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Covid-19 Vaccine by Region (2017-2022)
    8.2 Middle East & Africa Covid-19 Vaccine Market Size by Type (2017-2022)
    8.3 Middle East & Africa Covid-19 Vaccine Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Covid-19 Vaccine Market Forecast
    10.1 Global Covid-19 Vaccine Forecast by Regions (2023-2028)
        10.1.1 Global Covid-19 Vaccine Forecast by Regions (2023-2028)
        10.1.2 Americas Covid-19 Vaccine Forecast
        10.1.3 APAC Covid-19 Vaccine Forecast
        10.1.4 Europe Covid-19 Vaccine Forecast
        10.1.5 Middle East & Africa Covid-19 Vaccine Forecast
    10.2 Americas Covid-19 Vaccine Forecast by Country (2023-2028)
        10.2.1 United States Covid-19 Vaccine Market Forecast
        10.2.2 Canada Covid-19 Vaccine Market Forecast
        10.2.3 Mexico Covid-19 Vaccine Market Forecast
        10.2.4 Brazil Covid-19 Vaccine Market Forecast
    10.3 APAC Covid-19 Vaccine Forecast by Region (2023-2028)
        10.3.1 China Covid-19 Vaccine Market Forecast
        10.3.2 Japan Covid-19 Vaccine Market Forecast
        10.3.3 Korea Covid-19 Vaccine Market Forecast
        10.3.4 Southeast Asia Covid-19 Vaccine Market Forecast
        10.3.5 India Covid-19 Vaccine Market Forecast
        10.3.6 Australia Covid-19 Vaccine Market Forecast
    10.4 Europe Covid-19 Vaccine Forecast by Country (2023-2028)
        10.4.1 Germany Covid-19 Vaccine Market Forecast
        10.4.2 France Covid-19 Vaccine Market Forecast
        10.4.3 UK Covid-19 Vaccine Market Forecast
        10.4.4 Italy Covid-19 Vaccine Market Forecast
        10.4.5 Russia Covid-19 Vaccine Market Forecast
    10.5 Middle East & Africa Covid-19 Vaccine Forecast by Region (2023-2028)
        10.5.1 Egypt Covid-19 Vaccine Market Forecast
        10.5.2 South Africa Covid-19 Vaccine Market Forecast
        10.5.3 Israel Covid-19 Vaccine Market Forecast
        10.5.4 Turkey Covid-19 Vaccine Market Forecast
        10.5.5 GCC Countries Covid-19 Vaccine Market Forecast
    10.6 Global Covid-19 Vaccine Forecast by Type (2023-2028)
    10.7 Global Covid-19 Vaccine Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Inovio Pharmaceuticals
        11.1.1 Inovio Pharmaceuticals Company Information
        11.1.2 Inovio Pharmaceuticals Covid-19 Vaccine Product Offered
        11.1.3 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Inovio Pharmaceuticals Main Business Overview
        11.1.5 Inovio Pharmaceuticals Latest Developments
    11.2 Takis Biotech (Evvivax)
        11.2.1 Takis Biotech (Evvivax) Company Information
        11.2.2 Takis Biotech (Evvivax) Covid-19 Vaccine Product Offered
        11.2.3 Takis Biotech (Evvivax) Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Takis Biotech (Evvivax) Main Business Overview
        11.2.5 Takis Biotech (Evvivax) Latest Developments
    11.3 Zydus Cadila
        11.3.1 Zydus Cadila Company Information
        11.3.2 Zydus Cadila Covid-19 Vaccine Product Offered
        11.3.3 Zydus Cadila Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Zydus Cadila Main Business Overview
        11.3.5 Zydus Cadila Latest Developments
    11.4 Codagenix, Inc.
        11.4.1 Codagenix, Inc. Company Information
        11.4.2 Codagenix, Inc. Covid-19 Vaccine Product Offered
        11.4.3 Codagenix, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Codagenix, Inc. Main Business Overview
        11.4.5 Codagenix, Inc. Latest Developments
    11.5 GeoVax, Inc.
        11.5.1 GeoVax, Inc. Company Information
        11.5.2 GeoVax, Inc. Covid-19 Vaccine Product Offered
        11.5.3 GeoVax, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 GeoVax, Inc. Main Business Overview
        11.5.5 GeoVax, Inc. Latest Developments
    11.6 Bravovax
        11.6.1 Bravovax Company Information
        11.6.2 Bravovax Covid-19 Vaccine Product Offered
        11.6.3 Bravovax Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Bravovax Main Business Overview
        11.6.5 Bravovax Latest Developments
    11.7 Janssen Pharmaceutical Companies
        11.7.1 Janssen Pharmaceutical Companies Company Information
        11.7.2 Janssen Pharmaceutical Companies Covid-19 Vaccine Product Offered
        11.7.3 Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Janssen Pharmaceutical Companies Main Business Overview
        11.7.5 Janssen Pharmaceutical Companies Latest Developments
    11.8 Altimmune
        11.8.1 Altimmune Company Information
        11.8.2 Altimmune Covid-19 Vaccine Product Offered
        11.8.3 Altimmune Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Altimmune Main Business Overview
        11.8.5 Altimmune Latest Developments
    11.9 Vaxart
        11.9.1 Vaxart Company Information
        11.9.2 Vaxart Covid-19 Vaccine Product Offered
        11.9.3 Vaxart Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Vaxart Main Business Overview
        11.9.5 Vaxart Latest Developments
    11.10 CanSino Biologics
        11.10.1 CanSino Biologics Company Information
        11.10.2 CanSino Biologics Covid-19 Vaccine Product Offered
        11.10.3 CanSino Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 CanSino Biologics Main Business Overview
        11.10.5 CanSino Biologics Latest Developments
    11.11 ExpreS2ion Biotechnologies ApS
        11.11.1 ExpreS2ion Biotechnologies ApS Company Information
        11.11.2 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Product Offered
        11.11.3 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 ExpreS2ion Biotechnologies ApS Main Business Overview
        11.11.5 ExpreS2ion Biotechnologies ApS Latest Developments
    11.12 Clover Biopharmaceuticals
        11.12.1 Clover Biopharmaceuticals Company Information
        11.12.2 Clover Biopharmaceuticals Covid-19 Vaccine Product Offered
        11.12.3 Clover Biopharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Clover Biopharmaceuticals Main Business Overview
        11.12.5 Clover Biopharmaceuticals Latest Developments
    11.13 GSK
        11.13.1 GSK Company Information
        11.13.2 GSK Covid-19 Vaccine Product Offered
        11.13.3 GSK Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 GSK Main Business Overview
        11.13.5 GSK Latest Developments
    11.14 Vaxil Bio Ltd.
        11.14.1 Vaxil Bio Ltd. Company Information
        11.14.2 Vaxil Bio Ltd. Covid-19 Vaccine Product Offered
        11.14.3 Vaxil Bio Ltd. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Vaxil Bio Ltd. Main Business Overview
        11.14.5 Vaxil Bio Ltd. Latest Developments
    11.15 Generex
        11.15.1 Generex Company Information
        11.15.2 Generex Covid-19 Vaccine Product Offered
        11.15.3 Generex Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Generex Main Business Overview
        11.15.5 Generex Latest Developments
    11.16 Novavax, Inc.
        11.16.1 Novavax, Inc. Company Information
        11.16.2 Novavax, Inc. Covid-19 Vaccine Product Offered
        11.16.3 Novavax, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Novavax, Inc. Main Business Overview
        11.16.5 Novavax, Inc. Latest Developments
    11.17 Sanofi Pasteur
        11.17.1 Sanofi Pasteur Company Information
        11.17.2 Sanofi Pasteur Covid-19 Vaccine Product Offered
        11.17.3 Sanofi Pasteur Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Sanofi Pasteur Main Business Overview
        11.17.5 Sanofi Pasteur Latest Developments
    11.18 Baylor
        11.18.1 Baylor Company Information
        11.18.2 Baylor Covid-19 Vaccine Product Offered
        11.18.3 Baylor Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 Baylor Main Business Overview
        11.18.5 Baylor Latest Developments
    11.19 iBio, Inc.
        11.19.1 iBio, Inc. Company Information
        11.19.2 iBio, Inc. Covid-19 Vaccine Product Offered
        11.19.3 iBio, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 iBio, Inc. Main Business Overview
        11.19.5 iBio, Inc. Latest Developments
    11.20 Zydus Cadila
        11.20.1 Zydus Cadila Company Information
        11.20.2 Zydus Cadila Covid-19 Vaccine Product Offered
        11.20.3 Zydus Cadila Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.20.4 Zydus Cadila Main Business Overview
        11.20.5 Zydus Cadila Latest Developments
    11.21 Moderna, Inc.
        11.21.1 Moderna, Inc. Company Information
        11.21.2 Moderna, Inc. Covid-19 Vaccine Product Offered
        11.21.3 Moderna, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.21.4 Moderna, Inc. Main Business Overview
        11.21.5 Moderna, Inc. Latest Developments
    11.22 Curevac
        11.22.1 Curevac Company Information
        11.22.2 Curevac Covid-19 Vaccine Product Offered
        11.22.3 Curevac Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.22.4 Curevac Main Business Overview
        11.22.5 Curevac Latest Developments
    11.23 ImmunoPrecise
        11.23.1 ImmunoPrecise Company Information
        11.23.2 ImmunoPrecise Covid-19 Vaccine Product Offered
        11.23.3 ImmunoPrecise Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
        11.23.4 ImmunoPrecise Main Business Overview
        11.23.5 ImmunoPrecise Latest Developments
12 Research Findings and Conclusion
List of Tables
    Table 1. Covid-19 Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of DNA
    Table 3. Major Players of Live Attenuated Virus
    Table 4. Major Players of NonReplicating Viral Vecto
    Table 5. Major Players of Protein Subunit
    Table 6. Major Players of RNA
    Table 7. Covid-19 Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions)
    Table 9. Global Covid-19 Vaccine Market Size Market Share by Type (2017-2022)
    Table 10. Covid-19 Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions)
    Table 12. Global Covid-19 Vaccine Market Size Market Share by Application (2017-2022)
    Table 13. Global Covid-19 Vaccine Revenue by Players (2020-2022) & ($ Millions)
    Table 14. Global Covid-19 Vaccine Revenue Market Share by Player (2020-2022)
    Table 15. Covid-19 Vaccine Key Players Head office and Products Offered
    Table 16. Covid-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Covid-19 Vaccine Market Size by Regions 2017-2022 & ($ Millions)
    Table 20. Global Covid-19 Vaccine Market Size Market Share by Regions (2017-2022)
    Table 21. Americas Covid-19 Vaccine Market Size by Country (2017-2022) & ($ Millions)
    Table 22. Americas Covid-19 Vaccine Market Size Market Share by Country (2017-2022)
    Table 23. Americas Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions)
    Table 24. Americas Covid-19 Vaccine Market Size Market Share by Type (2017-2022)
    Table 25. Americas Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions)
    Table 26. Americas Covid-19 Vaccine Market Size Market Share by Application (2017-2022)
    Table 27. APAC Covid-19 Vaccine Market Size by Region (2017-2022) & ($ Millions)
    Table 28. APAC Covid-19 Vaccine Market Size Market Share by Region (2017-2022)
    Table 29. APAC Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions)
    Table 30. APAC Covid-19 Vaccine Market Size Market Share by Type (2017-2022)
    Table 31. APAC Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions)
    Table 32. APAC Covid-19 Vaccine Market Size Market Share by Application (2017-2022)
    Table 33. Europe Covid-19 Vaccine Market Size by Country (2017-2022) & ($ Millions)
    Table 34. Europe Covid-19 Vaccine Market Size Market Share by Country (2017-2022)
    Table 35. Europe Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions)
    Table 36. Europe Covid-19 Vaccine Market Size Market Share by Type (2017-2022)
    Table 37. Europe Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions)
    Table 38. Europe Covid-19 Vaccine Market Size Market Share by Application (2017-2022)
    Table 39. Middle East & Africa Covid-19 Vaccine Market Size by Region (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Region (2017-2022)
    Table 41. Middle East & Africa Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Type (2017-2022)
    Table 43. Middle East & Africa Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions)
    Table 44. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Application (2017-2022)
    Table 45. Key Market Drivers & Growth Opportunities of Covid-19 Vaccine
    Table 46. Key Market Challenges & Risks of Covid-19 Vaccine
    Table 47. Key Industry Trends of Covid-19 Vaccine
    Table 48. Global Covid-19 Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 49. Global Covid-19 Vaccine Market Size Market Share Forecast by Regions (2023-2028)
    Table 50. Global Covid-19 Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 51. Global Covid-19 Vaccine Market Size Market Share Forecast by Type (2023-2028)
    Table 52. Global Covid-19 Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 53. Global Covid-19 Vaccine Market Size Market Share Forecast by Application (2023-2028)
    Table 54. Inovio Pharmaceuticals Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 55. Inovio Pharmaceuticals Covid-19 Vaccine Product Offered
    Table 56. Inovio Pharmaceuticals Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 57. Inovio Pharmaceuticals Main Business
    Table 58. Inovio Pharmaceuticals Latest Developments
    Table 59. Takis Biotech (Evvivax) Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 60. Takis Biotech (Evvivax) Covid-19 Vaccine Product Offered
    Table 61. Takis Biotech (Evvivax) Main Business
    Table 62. Takis Biotech (Evvivax) Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 63. Takis Biotech (Evvivax) Latest Developments
    Table 64. Zydus Cadila Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 65. Zydus Cadila Covid-19 Vaccine Product Offered
    Table 66. Zydus Cadila Main Business
    Table 67. Zydus Cadila Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 68. Zydus Cadila Latest Developments
    Table 69. Codagenix, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 70. Codagenix, Inc. Covid-19 Vaccine Product Offered
    Table 71. Codagenix, Inc. Main Business
    Table 72. Codagenix, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 73. Codagenix, Inc. Latest Developments
    Table 74. GeoVax, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 75. GeoVax, Inc. Covid-19 Vaccine Product Offered
    Table 76. GeoVax, Inc. Main Business
    Table 77. GeoVax, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 78. GeoVax, Inc. Latest Developments
    Table 79. Bravovax Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 80. Bravovax Covid-19 Vaccine Product Offered
    Table 81. Bravovax Main Business
    Table 82. Bravovax Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 83. Bravovax Latest Developments
    Table 84. Janssen Pharmaceutical Companies Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 85. Janssen Pharmaceutical Companies Covid-19 Vaccine Product Offered
    Table 86. Janssen Pharmaceutical Companies Main Business
    Table 87. Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 88. Janssen Pharmaceutical Companies Latest Developments
    Table 89. Altimmune Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 90. Altimmune Covid-19 Vaccine Product Offered
    Table 91. Altimmune Main Business
    Table 92. Altimmune Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 93. Altimmune Latest Developments
    Table 94. Vaxart Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 95. Vaxart Covid-19 Vaccine Product Offered
    Table 96. Vaxart Main Business
    Table 97. Vaxart Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 98. Vaxart Latest Developments
    Table 99. CanSino Biologics Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 100. CanSino Biologics Covid-19 Vaccine Product Offered
    Table 101. CanSino Biologics Main Business
    Table 102. CanSino Biologics Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 103. CanSino Biologics Latest Developments
    Table 104. ExpreS2ion Biotechnologies ApS Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 105. ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Product Offered
    Table 106. ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 107. ExpreS2ion Biotechnologies ApS Main Business
    Table 108. ExpreS2ion Biotechnologies ApS Latest Developments
    Table 109. Clover Biopharmaceuticals Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 110. Clover Biopharmaceuticals Covid-19 Vaccine Product Offered
    Table 111. Clover Biopharmaceuticals Main Business
    Table 112. Clover Biopharmaceuticals Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 113. Clover Biopharmaceuticals Latest Developments
    Table 114. GSK Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 115. GSK Covid-19 Vaccine Product Offered
    Table 116. GSK Main Business
    Table 117. GSK Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 118. GSK Latest Developments
    Table 119. Vaxil Bio Ltd. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 120. Vaxil Bio Ltd. Covid-19 Vaccine Product Offered
    Table 121. Vaxil Bio Ltd. Main Business
    Table 122. Vaxil Bio Ltd. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 123. Vaxil Bio Ltd. Latest Developments
    Table 124. Generex Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 125. Generex Covid-19 Vaccine Product Offered
    Table 126. Generex Main Business
    Table 127. Generex Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 128. Generex Latest Developments
    Table 129. Novavax, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 130. Novavax, Inc. Covid-19 Vaccine Product Offered
    Table 131. Novavax, Inc. Main Business
    Table 132. Novavax, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 133. Novavax, Inc. Latest Developments
    Table 134. Sanofi Pasteur Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 135. Sanofi Pasteur Covid-19 Vaccine Product Offered
    Table 136. Sanofi Pasteur Main Business
    Table 137. Sanofi Pasteur Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 138. Sanofi Pasteur Latest Developments
    Table 139. Baylor Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 140. Baylor Covid-19 Vaccine Product Offered
    Table 141. Baylor Main Business
    Table 142. Baylor Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 143. Baylor Latest Developments
    Table 144. iBio, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 145. iBio, Inc. Covid-19 Vaccine Product Offered
    Table 146. iBio, Inc. Main Business
    Table 147. iBio, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 148. iBio, Inc. Latest Developments
    Table 149. Zydus Cadila Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 150. Zydus Cadila Covid-19 Vaccine Product Offered
    Table 151. Zydus Cadila Main Business
    Table 152. Zydus Cadila Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 153. Zydus Cadila Latest Developments
    Table 154. Moderna, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 155. Moderna, Inc. Covid-19 Vaccine Product Offered
    Table 156. Moderna, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 157. Moderna, Inc. Main Business
    Table 158. Moderna, Inc. Latest Developments
    Table 159. Curevac Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 160. Curevac Covid-19 Vaccine Product Offered
    Table 161. Curevac Main Business
    Table 162. Curevac Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 163. Curevac Latest Developments
    Table 164. ImmunoPrecise Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors
    Table 165. ImmunoPrecise Covid-19 Vaccine Product Offered
    Table 166. ImmunoPrecise Main Business
    Table 167. ImmunoPrecise Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 168. ImmunoPrecise Latest Developments
List of Figures
    Figure 1. Covid-19 Vaccine Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Covid-19 Vaccine Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Covid-19 Vaccine Market Size Market Share by Type in 2021
    Figure 7. Covid-19 Vaccine in Treatment
    Figure 8. Global Covid-19 Vaccine Market: Treatment (2017-2022) & ($ Millions)
    Figure 9. Covid-19 Vaccine in Prevention
    Figure 10. Global Covid-19 Vaccine Market: Prevention (2017-2022) & ($ Millions)
    Figure 11. Global Covid-19 Vaccine Market Size Market Share by Application in 2021
    Figure 12. Global Covid-19 Vaccine Revenue Market Share by Player in 2021
    Figure 13. Global Covid-19 Vaccine Market Size Market Share by Regions (2017-2022)
    Figure 14. Americas Covid-19 Vaccine Market Size 2017-2022 ($ Millions)
    Figure 15. APAC Covid-19 Vaccine Market Size 2017-2022 ($ Millions)
    Figure 16. Europe Covid-19 Vaccine Market Size 2017-2022 ($ Millions)
    Figure 17. Middle East & Africa Covid-19 Vaccine Market Size 2017-2022 ($ Millions)
    Figure 18. Americas Covid-19 Vaccine Value Market Share by Country in 2021
    Figure 19. Americas Covid-19 Vaccine Consumption Market Share by Type in 2021
    Figure 20. Americas Covid-19 Vaccine Market Size Market Share by Application in 2021
    Figure 21. United States Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 22. Canada Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 23. Mexico Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Brazil Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 25. APAC Covid-19 Vaccine Market Size Market Share by Region in 2021
    Figure 26. APAC Covid-19 Vaccine Market Size Market Share by Application in 2021
    Figure 27. China Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Japan Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Korea Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Southeast Asia Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 31. India Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Australia Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Europe Covid-19 Vaccine Market Size Market Share by Country in 2021
    Figure 34. Europe Covid-19 Vaccine Market Size Market Share by Type in 2021
    Figure 35. Europe Covid-19 Vaccine Market Size Market Share by Application in 2021
    Figure 36. Germany Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 37. France Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 38. UK Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Italy Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Russia Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Region in 2021
    Figure 42. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Type in 2021
    Figure 43. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Application in 2021
    Figure 44. Egypt Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 45. South Africa Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Israel Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Turkey Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 48. GCC Country Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Americas Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 50. APAC Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 51. Europe Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 52. Middle East & Africa Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 53. United States Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 54. Canada Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 55. Mexico Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 56. Brazil Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 57. China Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 58. Japan Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 59. Korea Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 60. Southeast Asia Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 61. India Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 62. Australia Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 63. Germany Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 64. France Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 65. UK Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 66. Italy Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 67. Russia Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 68. Spain Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 69. Egypt Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 70. South Africa Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 71. Israel Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 72. Turkey Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
    Figure 73. GCC Countries Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Covid-19 Vaccine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Covid-19 Vaccine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Covid-19 Vaccine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports